In CRC cases, elevated expression of ADAR1, BCLXL, ERCC1, HER3, and PR reflected a worse survival rate, whereas relatively high expression of MYH11 showed a better survival rate. This evidence concerns the gene BCL2L1 and colorectal carcinoma.